Angela Mastronuzzi shared on LinkedIn:

“Today begins Brain Tumor Awareness Month.

We dedicate May to brain tumor education, raising awareness and honoring those patients affected.
In 70% of pediatric cases the patients are healed, but there are pathologies that we are still unable to cure and recurrent tumors are not very treatable.

This is why there is a need for innovative therapies: a new clinical trial is now open on CAR T cells directed against GD2. Contact information in the link.

Special thank you to Banca Ifis for their support of this trial.”      .

Source: Angela Mastronuzzi/LinkedIn

Angela Mastronuzzi is pediatric hematologist-oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children’s Hospital (Italy). She is also a professor at the UniCamillus International Medical University, and a Board Member of AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica).

Her main fields of interest are CNS tumors and innovative therapies. She is the author of more than 180 scientific publications in peer-reviewed international journals.